CN115747992A - High-protein-content antibacterial thermoregulation cellulose fiber and preparation method thereof - Google Patents
High-protein-content antibacterial thermoregulation cellulose fiber and preparation method thereof Download PDFInfo
- Publication number
- CN115747992A CN115747992A CN202211452113.6A CN202211452113A CN115747992A CN 115747992 A CN115747992 A CN 115747992A CN 202211452113 A CN202211452113 A CN 202211452113A CN 115747992 A CN115747992 A CN 115747992A
- Authority
- CN
- China
- Prior art keywords
- protein
- antibacterial
- cellulose fiber
- thermoregulation
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920003043 Cellulose fiber Polymers 0.000 title claims abstract description 36
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 30
- 230000028016 temperature homeostasis Effects 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003094 microcapsule Substances 0.000 claims abstract description 29
- 239000012782 phase change material Substances 0.000 claims abstract description 29
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 28
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 16
- 239000000835 fiber Substances 0.000 claims abstract description 16
- 241000208340 Araliaceae Species 0.000 claims abstract description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 15
- 235000008434 ginseng Nutrition 0.000 claims abstract description 15
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims abstract description 13
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 claims abstract description 13
- 238000009987 spinning Methods 0.000 claims abstract description 13
- 229920000297 Rayon Polymers 0.000 claims abstract description 11
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 claims abstract description 7
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000002250 absorbent Substances 0.000 claims abstract description 5
- 230000002745 absorbent Effects 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 84
- 238000002156 mixing Methods 0.000 claims description 36
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 241000229143 Hippophae Species 0.000 claims description 19
- 238000001035 drying Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 229920002678 cellulose Polymers 0.000 claims description 15
- 239000001913 cellulose Substances 0.000 claims description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 10
- 239000004744 fabric Substances 0.000 claims description 10
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 230000001112 coagulating effect Effects 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- OEXNTAFMVQAGHV-UHFFFAOYSA-N 4-tert-butyl-2-pyridin-2-ylpyridine Chemical compound CC(C)(C)C1=CC=NC(C=2N=CC=CC=2)=C1 OEXNTAFMVQAGHV-UHFFFAOYSA-N 0.000 claims description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 239000002131 composite material Substances 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 6
- 230000008025 crystallization Effects 0.000 claims description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 claims description 6
- 239000000419 plant extract Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 239000005639 Lauric acid Substances 0.000 claims description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 5
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 claims description 5
- 238000006477 desulfuration reaction Methods 0.000 claims description 5
- 230000023556 desulfurization Effects 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 5
- 235000011152 sodium sulphate Nutrition 0.000 claims description 5
- 235000010265 sodium sulphite Nutrition 0.000 claims description 5
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 5
- 229960001763 zinc sulfate Drugs 0.000 claims description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 5
- 235000003935 Hippophae Nutrition 0.000 claims description 4
- HOWGUJZVBDQJKV-UHFFFAOYSA-N docosane Chemical compound CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- FNAZRRHPUDJQCJ-UHFFFAOYSA-N henicosane Chemical compound CCCCCCCCCCCCCCCCCCCCC FNAZRRHPUDJQCJ-UHFFFAOYSA-N 0.000 claims description 4
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims description 4
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- LQERIDTXQFOHKA-UHFFFAOYSA-N nonadecane Chemical compound CCCCCCCCCCCCCCCCCCC LQERIDTXQFOHKA-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- IVKNZCBNXPYYKL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 IVKNZCBNXPYYKL-UHFFFAOYSA-N 0.000 claims description 3
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical group C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 3
- 241000222122 Candida albicans Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 241000191967 Staphylococcus aureus Species 0.000 claims description 3
- 229910021542 Vanadium(IV) oxide Inorganic materials 0.000 claims description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 3
- 229940095731 candida albicans Drugs 0.000 claims description 3
- 235000020710 ginseng extract Nutrition 0.000 claims description 3
- 229940057995 liquid paraffin Drugs 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 238000005496 tempering Methods 0.000 claims description 3
- GRUMUEUJTSXQOI-UHFFFAOYSA-N vanadium dioxide Chemical compound O=[V]=O GRUMUEUJTSXQOI-UHFFFAOYSA-N 0.000 claims description 3
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 230000003009 desulfurizing effect Effects 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 230000032683 aging Effects 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 230000006750 UV protection Effects 0.000 abstract description 3
- 230000004087 circulation Effects 0.000 abstract description 2
- 239000004753 textile Substances 0.000 abstract description 2
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000013522 chelant Substances 0.000 description 4
- 229940089161 ginsenoside Drugs 0.000 description 4
- 229930182494 ginsenoside Natural products 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 3
- 235000008800 isorhamnetin Nutrition 0.000 description 3
- 125000000468 ketone group Chemical group 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229920002334 Spandex Polymers 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000004759 spandex Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000168254 Siro Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Artificial Filaments (AREA)
Abstract
The invention discloses a high-protein-content antibacterial thermoregulation cellulose fiber and a preparation method thereof, and relates to the technical field of functional cellulose fibers. The invention firstly makes D-glucuronic acid, cyanuric chloride and 2,2', 4' -tetrahydroxy benzophenone react to prepare a modified uvioresistant agent, then utilizes phase-change material and methyl methacrylate to form phase-change microcapsules, and finally adds uvioresistant absorbent, phase-change microcapsules, ginseng rootlets and sea buckthorn extracts into viscose pulp to carry out viscose spinning to obtain the high-protein-containing antibacterial thermoregulation cellulose fiber. The high-protein-content antibacterial thermoregulation cellulose fiber prepared by the invention has the effects of ultraviolet resistance and temperature regulation, and has the effects of improving circulation, resisting aging, improving the immunity of organisms and resisting bacteria. The fiber of the invention can be used in home textiles, clothing, non-woven industries and the like.
Description
Technical Field
The invention relates to the technical field of functional cellulose fibers, in particular to a high-protein-content antibacterial thermoregulation cellulose fiber and a preparation method thereof.
Background
The cellulose fiber product has the characteristics of good moisture absorption and air permeability and comfortable wearing, and is widely applied. However, most of the cellulose fibers in China are conventional varieties, and the varieties of functional fibers and differential fibers are few, so that the vigorous development of new varieties of high-performance and differential cellulose fibers is a main direction for the development of the field of cellulose fibers.
The phase-change material changes form along with temperature change and can provide latent heat, and the phase-change material absorbs and releases heat through solid-liquid conversion, so that the stability of the temperature of the human-clothing microenvironment is realized, the comfort of textiles is improved, and the wearing comfort of a human body is improved. However, the phase-change material is subjected to solid-liquid conversion during working, and in practical application, the problems of deformation, leakage and the like are caused, so that much inconvenience is brought.
Ultraviolet rays are radiation rays with the wavelength of 400-10 nm, and proper ultraviolet radiation can enhance the physique of a human body and the capability of resisting infectious diseases and promote the synthesis of vitamin D3 in the human body, when the ultraviolet radiation is too strong, illumination dermatitis can be generated, erythema, blisters, edema and the like appear on the skin, and skin cancer can be seriously caused. Ultraviolet radiation can also cause degradation of the fiber, affecting its performance.
The ginseng rootlets extract is a non-volatile brown granular solid extracted from ginseng rootlets, is rich in ginsenoside, can greatly tonify primordial qi, recover pulse, relieve depletion, tonify spleen, benefit lung, promote fluid production and calm nerves, and contains various amino acids, vitamins and the like. The sea-buckthorn is a common traditional Chinese medicinal material, is rich in fat, protein and vitamins, and has the effects of softening blood vessels, promoting blood circulation, removing blood stasis, improving circulation, resisting aging, improving the immune function of the organism and resisting bacteria.
The invention utilizes the phase-change material, the ginseng rootlets extract and the sea buckthorn extract to prepare the cellulose fiber with the effects of ultraviolet resistance, temperature regulation and long-acting health care, so as to meet the demand of diversified functions of the garment material of people.
Disclosure of Invention
The invention aims to provide a high-protein-content antibacterial thermoregulation cellulose fiber and a preparation method thereof, and aims to solve the problems in the prior art.
In order to solve the technical problems, the invention provides the following technical scheme:
the high-protein-content antibacterial thermoregulation cellulose fiber is prepared by mixing and spinning an anti-ultraviolet absorbent, phase-change microcapsules, a plant extract and viscose pulp.
Further, the modified uvioresistant agent is prepared by reacting D-glucuronic acid, cyanuric chloride and 2,2', 4' -tetrahydroxy benzophenone.
Further, the phase change material microcapsule is prepared from a phase change material and methyl methacrylate; the plant extract at least contains one of Leptoradix Ginseng extract and fructus Hippophae extract.
Furthermore, the melting enthalpy value and the crystallization enthalpy value of the fiber are both between 5 and 50J/g.
Further, according to the claim 3, the antibacterial and thermoregulation cellulose fiber containing high protein is characterized in that the antibacterial effect of the fiber measured by GB/T20944.3-2008 oscillation method is that the inhibition rate of the fabric on staphylococcus aureus, escherichia coli and candida albicans is more than 85% after the fabric is washed for 50 times in ordinary families.
Further, a preparation method of the high-protein-content antibacterial thermoregulation cellulose fiber comprises the following preparation steps:
(1) Mixing the phase change material microcapsule, the ginseng fibrous extract and the sea buckthorn extract according to a mass ratio of 1.2 to 0.5;
(2) Mixing cyanuric chloride and acetone according to a mass ratio of 1-1;
(3) Mixing D-glucuronic acid, zinc powder, nickel powder, 4 '-tert-butyl-2.2' -bipyridine, an uvioresistant agent and magnesium chloride according to a mass ratio of 40;
(4) Mixing the modified uvioresistant agent, the viscose pulp, the polyethylene glycol with the molecular weight of 1000-2500 and the composite microcapsule according to the mass ratio of 1.3.
Further, the preparation method of the phase-change material microcapsule in the step (1) comprises the following steps: mixing a phase change material, an emulsifier, an initiator and distilled water according to a mass ratio of 100: 0.5.
Further, the phase-change material is one or a mixture of more of liquid paraffin, n-hexadecane, n-octadecane, nonadecane, n-eicosane, n-heneicosane, n-docosane or vanadium dioxide; the emulsifier is one or a mixture of Tween-80, span-80, sodium dodecyl sulfate or OP-10; the initiator is benzoyl peroxide or azobisisobutyronitrile.
Further, the preparation method of the viscose pulp in the step (4) comprises the following steps: dissolving sodium hydroxide in deionized water with the mass of 4-5 times that of the sodium hydroxide to obtain caustic soda solution; soaking cellulose pulp in a caustic soda solution according to the material-liquid ratio of 1-20 to 1; mixing alkali cellulose, carbon disulfide, deionized water and sodium hydroxide according to the mass ratio of 1.
Further, the spinning and post-treatment in the step (4) are specifically as follows: coagulating bath spinning, drawing, cutting, desulfurizing bath process, oiling bath, water washing and drying; the coagulating bath is specifically: 75-95 g/L of sulfuric acid, 260-290 g/L of sodium sulfate and 25-35 g/L of zinc sulfate; the desulfurization bath is specifically as follows: 2-6 g/L of sodium sulfite; the upper oil bath specifically comprises: 1.5-6.0 g/L of lauric acid; the washing times are 2-4 times; the drying temperature is 80-95 ℃, and the drying time is 2.5-4.0 h.
Compared with the prior art, the invention has the following beneficial effects:
the high-protein antibacterial thermoregulation cellulose fiber is prepared by mixing and spinning the anti-ultraviolet absorbent, the phase-change microcapsule, the plant extract and the viscose pulp, and has elasticity and thermoregulation performance.
Firstly, the uvioresistant agent is prepared by the reaction of D-glucuronic acid, cyanuric chloride and 2,2', 4' -tetrahydroxy benzophenone; 2,3', 4', 6-pentahydroxyl benzophenone and cyanuric chloride react to prepare an uvioresistant agent, nitrogen atoms in the uvioresistant agent can form intramolecular hydrogen bonds with the hydroxyl groups to form a six-membered chelate ring, and the six-membered chelate ring and surrounding structures form a conjugated pi electron system which can absorb ultraviolet light, so that the fiber achieves the uvioresistant effect; chlorine in the uvioresistant agent reacts with carboxyl in D-glucuronic acid to generate ketone group, so as to prepare the modified uvioresistant agent, and the ketone group can form intramolecular hydrogen bond with hydroxyl, so that the uvioresistant effect is enhanced; in addition, the glycosyl can relieve the stimulation of the ultraviolet resistant agent to the skin, improve the comfort level of the fiber and endow the ultraviolet resistant agent with good water solubility and biological safety; chlorine in the modified uvioresistant agent is combined with hydroxyl in the viscose pulp, so that the binding force between the modified uvioresistant agent and the viscose pulp is enhanced, and the uvioresistant effect is enhanced.
Secondly, the phase-change microcapsule is prepared by polymerizing methyl methacrylate on the surface of the phase-change material, so that the shape of the phase-change material can be maintained, and the leakage of the phase-change process of the phase-change material is prevented; the phase-change material microcapsule surface adsorbs Leptoradix Ginseng and fructus Hippophae extract, and ginsenoside and isorhamnetin in the extract have effects of improving body condition, regulating nerve, delaying aging, resisting oxidation, resisting tumor, protecting cardiovascular system, and resisting bacteria, so that the fiber has health promotion effect; then the beta-cyclodextrin is used for inclusion, so that the ginseng fibrous root and the sea buckthorn extract can be slowly released to achieve a lasting effect; in addition, hydroxyl on the surface of the microcapsule can react with chlorine in the modified uvioresistant agent, so that the bonding force between the microcapsule and the fiber is improved, and the temperature regulation effect is enhanced.
The invention relates to a high-protein antibacterial thermoregulation cellulose fiber, which contains benzophenone ultraviolet absorbent, phase-change microcapsule, ginseng rootlets, sea buckthorn extract and the like.
The high-protein-content antibacterial thermoregulation cellulose fiber is characterized in that the plant extract at least contains one of ginseng rootlets extract and sea buckthorn extract; wherein the Leptoradix Ginseng extract contains ginsenoside, and the fructus Hippophae extract contains isorhamnetin; preferably, the content of ginsenoside in the fiber is more than 1.5ppm, and the content of isorhamnetin is more than 1.5 ppm.
The high-protein-content antibacterial thermoregulation cellulose fiber has the advantages that the linear density of the fiber is between 1.2D and 10D, the grain size of the phase-change microcapsule is between 0.5 and 3.5 mu m, and the melting enthalpy value and the crystallization enthalpy value are both above 5 to 50J/g; preferably, the linear density of the fiber is between 1.2D and 6D, the grain diameter of the phase-change microcapsule is between 0.5 and 2.5 mu m, and the melting enthalpy value and the crystallization enthalpy value are both between 5 and 30J/g.
The protein content in the high-protein antibacterial thermoregulation cellulose fiber is derived from ginseng rootlets and sea buckthorn extracts, wherein the protein content in the sea buckthorn extracts is quite high and is about 30-40%. 1/5 of the protein in the seabuckthorn extract is in a free state and is particularly easy to be absorbed by a human body. In addition, the sea buckthorn contains a large number of amino acids, of which 7 are essential amino acids.
The result of the antibacterial effect test of the high-protein-content antibacterial thermoregulation cellulose fiber by using the GB/T20944.3-2008 oscillation method is that the bacteriostatic rate of the fabric on staphylococcus aureus, escherichia coli and candida albicans is more than 85% after the fabric is washed for 50 times in a common family.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without making any creative effort based on the embodiments in the present invention, belong to the protection scope of the present invention.
The method provided by the present invention is illustrated in detail by the following examples for more clear illustration, and the method for testing each index of the high protein antibacterial thermoregulation cellulose fiber prepared in the following examples is as follows:
spinning the high-protein antibacterial temperature-regulating cellulose fiber prepared in the examples and the comparative examples into 40s siro compact yarn, weaving into polyurethane sweat cloth fabric by using a 28-needle big circle, wherein the gram weight is 150-170 g/m 2 ；
The ultraviolet resistance effect is as follows: and testing UPF and UVA of the spandex single jersey fabric according to GB/T18830.
Temperature regulation effect: and testing the melting enthalpy value and the crystallization enthalpy value of the spandex single jersey fabric according to EN 16806.
Example 1
(1) Mixing liquid paraffin, tween-80, benzoyl peroxide and distilled water according to a mass ratio of 100;
(2) Mixing a phase change material microcapsule, a ginseng rootlet extract and a sea buckthorn extract according to a mass ratio of 1.2;
(3) Mixing cyanuric chloride and acetone according to the mass ratio of 1 to 10, swelling for 10min at 200rpm and 0 ℃, adding 2,2', 4' -tetrahydroxybenzophenone which is 1 time of the mass of the cyanuric chloride and sodium hydroxide which is 0.9 time of the mass of the cyanuric chloride, continuously reacting for 3h, carrying out rotary evaporation for 20min at 40 ℃ and 200rpm, washing for 3 times by using distilled water, and drying for 5h at 40 ℃ to obtain the uvioresistant agent;
(4) Mixing D-glucuronic acid, zinc powder, nickel powder, 4 '-tert-butyl-2.2' -bipyridine, an uvioresistant agent and magnesium chloride according to a mass ratio of 40;
(5) Dissolving sodium hydroxide in deionized water with the mass 4 times that of the sodium hydroxide to obtain a caustic soda solution; soaking cellulose pulp in a caustic soda solution according to a material-liquid ratio of 1; mixing alkali cellulose, carbon disulfide, deionized water and sodium hydroxide according to the mass ratio of 1;
(6) Mixing a modified anti-ultraviolet agent, a cellulose spinning solution, polyethylene glycol with the molecular weight of 1000 and a composite microcapsule according to the mass ratio of 1.3; the coagulating bath is specifically as follows: 75g/L of sulfuric acid, 260g/L of sodium sulfate and 25g/L of zinc sulfate; the desulfurization bath specifically comprises: 2g/L of sodium sulfite; the oil bath is characterized in that: 1.5g/L of lauric acid; the washing times are 2 times; the drying temperature is 80 ℃, and the drying time is 2.5h.
Example 2
(1) Mixing n-octadecane, sodium dodecyl sulfate, azobisisobutyronitrile and distilled water according to a mass ratio of 100;
(2) Mixing the phase change material microcapsule, the ginseng fibrous extract and the sea buckthorn extract according to a mass ratio of 3.2;
(3) Mixing cyanuric chloride and acetone according to the mass ratio of 1 to 15, swelling at 250rpm and 0 ℃ for 10min, adding 2,2', 4' -tetrahydroxybenzophenone which is 1.5 times of the mass of cyanuric chloride and sodium hydroxide which is 1.0 times of the mass of cyanuric chloride, continuously reacting for 4h, carrying out rotary evaporation at 40 ℃ and 200rpm for 20min, washing with distilled water for 4 times, and drying at 50 ℃ for 5h to obtain the uvioresistant agent;
(4) Mixing D-glucuronic acid, zinc powder, nickel powder, 4 '-tert-butyl-2.2' -bipyridine, an uvioresistant agent and magnesium chloride according to a mass ratio of 45;
(5) Dissolving sodium hydroxide in deionized water with the mass 5 times that of the sodium hydroxide to obtain a caustic soda solution; soaking cellulose pulp in a caustic soda solution according to a material-liquid ratio of 1; mixing alkali cellulose, carbon disulfide, deionized water and sodium hydroxide according to the mass ratio of 1;
(6) Mixing a modified anti-ultraviolet agent, a cellulose spinning solution, polyethylene glycol with the molecular weight of 2000 and a composite microcapsule according to the mass ratio of 1.4; the coagulating bath is specifically: 85g/L sulfuric acid, 275g/L sodium sulfate and 30g/L zinc sulfate; the desulfurization bath specifically comprises: 3.5g/L of sodium sulfite; the oil bath is characterized in that: 4g/L of lauric acid; the washing times are 3 times; the drying temperature is 90 ℃, and the drying time is 3h.
Example 3
(1) Mixing vanadium dioxide, OP-10, azobisisobutyronitrile and distilled water according to a mass ratio of 100;
(2) Mixing the phase change material microcapsules, the ginseng rootlets extract and the sea buckthorn extract according to a mass ratio of 5.2 to 0.8, standing for 4 hours, drying at 60 ℃ for 5 hours, adding a porous starch-ethanol solution with the mass 5 times that of the phase change material microcapsules, wherein the mass ratio of the porous starch to the absolute ethanol in the porous starch-ethanol solution is 1;
(3) Mixing cyanuric chloride and acetone according to the mass ratio of 1 to 20, swelling at 300rpm and 0 ℃ for 10min, adding 2,2', 4' -tetrahydroxybenzophenone which is 2 times of the mass of cyanuric chloride and sodium hydroxide which is 1.1 times of the mass of cyanuric chloride, continuously reacting for 5h, carrying out rotary evaporation at 40 ℃ and 200rpm for 20min, washing with distilled water for 5 times, and drying at 60 ℃ for 5h to obtain the uvioresistant agent;
(4) Mixing D-glucuronic acid, zinc powder, nickel powder, 4 '-tert-butyl-2.2' -bipyridine, an uvioresistant agent and magnesium chloride according to a mass ratio of 50;
(5) Dissolving sodium hydroxide in deionized water 6 times of the mass of the sodium hydroxide to obtain a caustic soda solution; soaking cellulose pulp in a caustic soda solution according to a material-liquid ratio of 1:40 for 50min at 60 ℃, squeezing for 4 times, and aging for 20h at 50 ℃ to prepare alkali cellulose; mixing alkali cellulose, carbon disulfide, deionized water and sodium hydroxide according to a mass ratio of 1;
(6) Mixing the modified uvioresistant agent, the cellulose spinning solution, polyethylene glycol with the molecular weight of 2500 and the composite microcapsule according to a mass ratio of 1.5; the coagulating bath is specifically: 95g/L of sulfuric acid, 290g/L of sodium sulfate and 35g/L of zinc sulfate; the desulfurization bath is specifically as follows: 6g/L of sodium sulfite; the oil bath is characterized in that: 6.0g/L of lauric acid; the washing times are 4 times; the drying temperature is 95 ℃, and the drying time is 4.0h.
Comparative example 1
Comparative example 1 differs from example 2 in that step (3) is not present and step (4) is changed to: mixing D-glucuronic acid, zinc powder, nickel powder, 4 '-tert-butyl-2.2' -bipyridine, cyanuric chloride and magnesium chloride according to a mass ratio of 45. The rest of the procedure was the same as in example 2.
Comparative example 2
Comparative example 2 differs from example 2 in that step (4) is eliminated and step (6) is changed to: mixing an anti-ultraviolet agent, a cellulose spinning solution, polyethylene glycol with molecular weight of 2000 and a composite microcapsule according to a mass ratio of 1. The rest of the procedure was the same as in example 2.
Comparative example 3
Comparative example 3 differs from example 2 in that step (1) is eliminated and step (2) is changed to: mixing the phase change material, the ginseng rootlets extract and the sea buckthorn extract according to a mass ratio of 3.2. The rest of the procedure was the same as in example 2.
Effects of the invention
Table 1 below shows the results of performance analysis of the high protein-containing antimicrobial tempering cellulose fibers using examples 1 to 3 of the present invention and comparative examples 1 to 3.
TABLE 1
The comparison of the UPF value and the UVA value data of the examples in the table 1 with the comparative examples shows that the modified uvioresistant agent synthesized by 2,3', 4', 6-pentahydroxybenzophenone, cyanuric chloride and D-glucuronic acid has excellent uvioresistant performance, after the 2,3', 4', 6-pentahydroxybenzophenone reacts with the cyanuric chloride, a six-membered chelate ring can be formed through intramolecular hydrogen bonds, and the six-membered chelate ring and the surrounding structure form a conjugated pi-electron system which can absorb ultraviolet light, so that the fiber achieves the uvioresistant effect; d-glucuronic acid reacts with chlorine atoms to generate ketone groups which can form intramolecular hydrogen bonds with hydroxyl groups, so that the anti-ultraviolet effect is enhanced; the comparison of the melting enthalpy value and the crystallization enthalpy value data of the examples and the comparative examples in the table 1 shows that the methyl methacrylate is polymerized on the surface of the phase change material to form the phase change material microcapsule, so that the shape of the phase change material can be maintained, the leakage of the phase change process can be prevented, and the gain temperature adjusting effect can be achieved.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. Any reference sign in a claim should not be construed as limiting the claim concerned.
Claims (10)
1. The high-protein-content antibacterial thermoregulation cellulose fiber is characterized by being prepared by mixing and spinning an ultraviolet-resistant absorbent, phase-change microcapsules, a plant extract and viscose pulp.
2. The high-protein-content antibacterial thermoregulation cellulose fiber according to claim 1, characterized in that the ultraviolet resistant agent is prepared by reacting D-glucuronic acid, cyanuric chloride and 2,2', 4' -tetrahydroxybenzophenone.
3. The high protein containing antibacterial tempering cellulose fiber of claim 1, wherein said phase change material microcapsule is made of phase change material, methyl methacrylate; the plant extract at least contains one of Leptoradix Ginseng extract and fructus Hippophae extract.
4. The high protein containing antimicrobial tempering cellulose fiber of claim 1, wherein said fiber has a melting enthalpy and a crystallization enthalpy between 5 and 50J/g.
5. The high-protein-content antibacterial and temperature-adjusting cellulose fiber as claimed in claim 1, wherein the antibacterial effect of the fiber measured by GB/T20944.3-2008 oscillation method is that the inhibition rate of the fabric on staphylococcus aureus, escherichia coli and candida albicans is above 85% after the fabric is washed for 50 times in a common household.
6. The preparation method of the high-protein-content antibacterial thermoregulation cellulose fiber is characterized by comprising the following preparation steps:
(1) Mixing a phase change material microcapsule, a ginseng fibrous extract and a sea buckthorn extract according to a mass ratio of 1.2;
(2) Mixing cyanuric chloride and acetone according to a mass ratio of 1-1;
(3) Mixing D-glucuronic acid, zinc powder, nickel powder, 4 '-tert-butyl-2.2' -bipyridine, an uvioresistant agent and magnesium chloride according to a mass ratio of 40;
(4) Mixing the modified uvioresistant agent, the viscose pulp, the polyethylene glycol with the molecular weight of 1000-2500 and the composite microcapsule according to the mass ratio of 1.3.
7. The method for preparing the high-protein antibacterial thermoregulation cellulose fiber according to claim 6, wherein the phase-change material microcapsule in step (1) is prepared by: mixing a phase change material, an emulsifier, an initiator and distilled water according to a mass ratio of 100.5.
8. The method for preparing high-protein-content antibacterial and thermoregulation cellulose fiber according to claim 6, wherein the phase-change material is one or more of liquid paraffin, n-hexadecane, n-octadecane, nonadecane, n-eicosane, n-heneicosane, n-docosane or vanadium dioxide; the emulsifier is one or a mixture of Tween-80, span-80, sodium dodecyl sulfate or OP-10; the initiator is benzoyl peroxide or azobisisobutyronitrile.
9. The method for preparing the antibacterial temperature-regulating cellulose fiber containing high protein according to claim 5, wherein the preparation method of the viscose pulp in the step (4) comprises the following steps: dissolving sodium hydroxide in deionized water with the mass of 4-5 times that of the sodium hydroxide to obtain caustic soda solution; soaking cellulose pulp in a caustic soda solution according to the material-liquid ratio of 1-20 to 1; mixing alkali cellulose, carbon disulfide, deionized water and sodium hydroxide according to the mass ratio of 1.1.
10. The method for preparing the high-protein antibacterial thermoregulation cellulose fiber according to the claim 5, wherein the spinning and post-treatment in the step (4) are specifically: coagulating bath spinning, drawing, cutting, desulfurizing bath process, oiling bath, water washing and drying; the coagulating bath is specifically: 75-95 g/L of sulfuric acid, 260-290 g/L of sodium sulfate and 25-35 g/L of zinc sulfate; the desulfurization bath is specifically as follows: 2-6 g/L of sodium sulfite; the oil bath is characterized in that: 1.5-6.0 g/L of lauric acid; the washing times are 2-4 times; the drying temperature is 80-95 ℃, and the drying time is 2.5-4.0 h.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211452113.6A CN115747992A (en) | 2022-11-21 | 2022-11-21 | High-protein-content antibacterial thermoregulation cellulose fiber and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211452113.6A CN115747992A (en) | 2022-11-21 | 2022-11-21 | High-protein-content antibacterial thermoregulation cellulose fiber and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115747992A true CN115747992A (en) | 2023-03-07 |
Family
ID=85333066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211452113.6A Pending CN115747992A (en) | 2022-11-21 | 2022-11-21 | High-protein-content antibacterial thermoregulation cellulose fiber and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115747992A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1332787A (en) * | 1998-10-23 | 2002-01-23 | 宝洁公司 | Fabrid care composition and method |
| US20110250256A1 (en) * | 2007-08-10 | 2011-10-13 | Genic Co, Ltd. | Dissolvable Nano Web Porous Film and Method of Preparing the Same |
| CN105316784A (en) * | 2015-12-02 | 2016-02-10 | 山传雷 | Composite microcapsule additive containing phase change material and sarcandra glabra extract and application of composite microcapsule additive |
| WO2016082798A1 (en) * | 2014-11-27 | 2016-06-02 | 陈河如 | α-CYAN-4-HYDROXYCINNAMIC ACID DERIVATIVE AND PREPARATION METHOD AND USE THEREOF |
| CN107022800A (en) * | 2017-03-24 | 2017-08-08 | 山传雷 | A kind of high heat storage amount phase-changing and temperature-regulating viscose rayon and preparation method thereof |
| WO2020113903A1 (en) * | 2018-12-04 | 2020-06-11 | 江苏金太阳纺织科技股份有限公司 | Skincare and antibacterial microcapsule finishing agent, and preparation method therefor and application thereof |
| AU2020101555A4 (en) * | 2020-07-29 | 2020-09-03 | Tianjin University Of Science And Technology | Fluorinated-sugar modified paclitaxel and its synthesis and application |
| CN113005551A (en) * | 2021-03-08 | 2021-06-22 | 镧明材料技术(上海)有限公司 | Rare earth-added ultraviolet-resistant anti-aging viscose fiber and preparation method thereof |
-
2022
- 2022-11-21 CN CN202211452113.6A patent/CN115747992A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1332787A (en) * | 1998-10-23 | 2002-01-23 | 宝洁公司 | Fabrid care composition and method |
| US20110250256A1 (en) * | 2007-08-10 | 2011-10-13 | Genic Co, Ltd. | Dissolvable Nano Web Porous Film and Method of Preparing the Same |
| WO2016082798A1 (en) * | 2014-11-27 | 2016-06-02 | 陈河如 | α-CYAN-4-HYDROXYCINNAMIC ACID DERIVATIVE AND PREPARATION METHOD AND USE THEREOF |
| CN105316784A (en) * | 2015-12-02 | 2016-02-10 | 山传雷 | Composite microcapsule additive containing phase change material and sarcandra glabra extract and application of composite microcapsule additive |
| CN107022800A (en) * | 2017-03-24 | 2017-08-08 | 山传雷 | A kind of high heat storage amount phase-changing and temperature-regulating viscose rayon and preparation method thereof |
| WO2020113903A1 (en) * | 2018-12-04 | 2020-06-11 | 江苏金太阳纺织科技股份有限公司 | Skincare and antibacterial microcapsule finishing agent, and preparation method therefor and application thereof |
| AU2020101555A4 (en) * | 2020-07-29 | 2020-09-03 | Tianjin University Of Science And Technology | Fluorinated-sugar modified paclitaxel and its synthesis and application |
| CN113005551A (en) * | 2021-03-08 | 2021-06-22 | 镧明材料技术(上海)有限公司 | Rare earth-added ultraviolet-resistant anti-aging viscose fiber and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张明政;沈云;甄莉莉;黄丹;: "新型紫外线吸收剂的合成及其在棉织物中的应用", 纺织学报, vol. 35, no. 02, pages 257 - 55 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100457990C (en) | Producing method and use for common and functional calcium alginate fiber | |
| CN111560663B (en) | Preparation method of cross-shaped skin-core moisture absorption and moisture removal fiber | |
| CN105544210B (en) | A kind of preparation method of the fabric step treating reagent based on modified fibroin protein solution | |
| CN101381907B (en) | Method for producing antimicrobial calcium alginate fiber | |
| CN107988652B (en) | Composite fiber containing lotus leaf extract and lotus seed extract and preparation method thereof | |
| CN111251693A (en) | Method for preparing underwear with antibacterial effect by using electrostatic spinning method | |
| CN110820334A (en) | Composite fiber containing wheat protein and preparation method thereof | |
| CN112226865B (en) | Deodorant insole material and preparation method thereof | |
| CN114000224A (en) | Preparation method of antibacterial moisture-absorbing heating fiber containing plant extract | |
| CN110965149A (en) | Water lily protein fiber and preparation process thereof | |
| CN110861363A (en) | High-strength TPU composite thermal fabric and preparation method thereof | |
| CN116288867A (en) | Antibacterial deodorizing multifunctional textile material and preparation method thereof | |
| CN113201936A (en) | Moisture-keeping antibacterial face-beautifying fabric containing aloe extract for bedding | |
| CN108691063B (en) | Blended and interwoven fabric of mint fibers, soybean fibers and polyester fibers and manufacturing method thereof | |
| CN115029849A (en) | Multifunctional warm-keeping knitted fabric and preparation method thereof | |
| CN115747992A (en) | High-protein-content antibacterial thermoregulation cellulose fiber and preparation method thereof | |
| CN108486882A (en) | A kind of preparation method of antibacterial crease-resistant Silk Finishing agent | |
| CN107881770A (en) | A kind of antibacterial processing method of alginate fibre thermal underwear face fabric | |
| CN109252294B (en) | High-strength hot-air seaweed membrane cloth and preparation method thereof | |
| CN114934324B (en) | Preparation method of hyaluronic acid cellulose fibers | |
| CN112831125B (en) | Antibacterial skin-care polypropylene fiber master batch and fabric | |
| CN114775088A (en) | Soybean protein plant traditional Chinese medicine multifunctional viscose fiber and preparation method thereof | |
| CN101046004A (en) | Coral viscose fiber and its production process | |
| CN110257940B (en) | Cattail pollen viscose fiber and preparation method thereof | |
| CN111155198A (en) | Preparation method of antibacterial polyester fiber |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |